History

Nanopores Office
Company History
Oxford Nanopore Technologies was spun out from the University of Oxford in 2005. Until May 2008, the company was named Oxford NanoLabs Ltd.

The company was founded by Professor Hagan Bayley, who is currently Professor of Chemical Biology at the University of Oxford, in partnership with IP Group plc. Since its inception, the Company has focused on developing the pioneering work of Professor Bayley and our other collaborators into a mass producible biochip and reader system for molecular analysis.

The development of a technology platform for molecular sensing based on nanopore technology is the culmination of nearly two decades of of research by Professor Bayley and our other collaborators, at a number of the world's most prestigious academic institutions including the University of Oxford, Harvard, MIT, the University of Massachusetts, the University of California Santa Cruz and Texas A&M University. Oxford Nanopore has a strong intellectual property position for the use of nanopores in molecular analysis and specifically DNA sequencing. 

In the summer of 2008, the company announced the creation of an exceptional Technology Advisory Board, including leading nanopore academics from around the world.  It also announced a series of IP collaborations with leading institutions, allowing the Company to take a leadership position in the development of immediate and future generations of nanopore DNA sequencing technologies and other nanopore applications.

In 2005, Dr Gordon Sanghera joined Oxford Nanopore as CEO. Gordon brings his experience of combining biological and electronic technologies; he previously delivered blood glucose sensing products to the market, transforming the lives of diabetes patients worldwide. Gordon now leads an experienced management team towards the development and commercialisation of a new gold-standard in DNA sequencing products. 

In 2008, Dr John Milton and Clive G Brown joined the executive management team, bringing experience developing the current world-leading DNA sequencing system.

In July 2009, the Company relocated to the Oxford Science Park.  Our new premises at Edmund Cartwright House were inaugurated by the UK Science and Innovation Minister, Lord Drayson.
Finance History
To date, the Company has raised nearly £50 million in five rounds of private funding, from a combination of private and institutional investors.

Seed funding was obtained in two rounds, from IP Group in 2005. In June 2006 the company raised £7.75m, and in March 2008 the company raised a further £10m.  

In January 2009 the Company announced an $18 million (£11.9 million) investment from Illumina and additional £2.1 million in private investment.

In February 2010 Oxford Nanopore raised £17.4 million from existing investors and new, undisclosed US-based investors.